Naltrexone treatment of comorbid alcohol and cocaine use disorders

Psychopharmacology

Volumn 139, Issue 1-2, 1998, Pages 44-52

  Hersh, David ^a   Van Kirk, Jeffrey R ^a   Kranzler, Henry R ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Alcohol dependence; Cocaine dependence; Naltrexone; Pharmacotherapy

Indexed keywords

ALCOHOL; COCAINE; NALTREXONE; PLACEBO; RIBOFLAVIN;

ABDOMINAL PAIN; ADULT; ALCOHOLISM; ANOREXIA; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DROWSINESS; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; URINALYSIS; VERTIGO;

ADULT; ALCOHOL DETERRENTS; ALCOHOL DRINKING; ALCOHOLISM; COCAINE-RELATED DISORDERS; COMPLIANCE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NALTREXONE;

EID: 0031690439     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050688     Document Type: Article

References (39)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised. APA, Washington, D.C.
2. Bilsky E, Montegut M, Delong C, Reid L (1992) Opioidergic modulation of cocaine conditioned place preferences. Life Sci 50:85-90
3. Bohn MJ, Kranzler HR, Beazoglou D, Staehler BA (1994) Naltrexone and brief counseling to reduce heavy drinking. Am J Addict 2:91-99
4. Bohn MJ, Krahn DD, Staehler BA (1995) Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19:600-606
5. Brown TG, Seraganian P, Tremblay J (1993) Alcohol and cocaine abusers 6 months after traditional treatment: do they fare as well as problem drinkers? J Subst Abuse Treat 10:545-552
6. Carroll KM, Ziedonis D, O'Malley S, McCance-Katz E, Gordon L, Rounsaville B (1993) Pharmacologic Interventions for alcohol- and cocaine-abusing individuals, a pilot study of disulfiram vs. naltrexone. Am J Addict 2:77-80
7. Chaney EF (1989) Social skills training. In: Hester RK, Miller WR (eds) Handbook of alcoholism treatment approaches: effective alternatives. Pergamon Press, New York, pp 206-221
8. Corrigall W, Coen K (1991) Opiate antagonists reduce cocaine hut not nicotine self-administration. Psychopharmacology 104: 167-170
9. Dackis CA, Gold MS (1985) Bromocriptine as a treatment of cocaine abuse. Lancet 2:1151-1152
10. De Vry J, Donselaar I, Van Ree JM (1989) Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol. J Pharmacol Exp Ther 251:735-740
11. Del Boca FK, Kranzler HR, Brown J, Korner P (1996) Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res 20:1412-1417
12. Gawin FH (1988) Chronic neuropharmacology of cocaine: progress in pharmacotherapy. J Clin Psychiatry 49 [Suppl]:11-16
13. Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203-223
14. Hesselbrock MN, Meyer RE, Keener JJ (1985) Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 42:1050-1055
15. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G (1993) Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 150:763-769
16. Houdi A, Bardo M, Van Loon G (1989) Opioid mediation of cocaine-induced hyperactivity and reinforcement Brain Res 497: 195-198
17. Johnson PO, Neyman J (1936) Tests of certain linear hypotheses and their application to some educational problems. Statist Res Mem 1:57-93
18. Kosten T, Kleber H, Morgan C (1989) Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44:887-892
19. Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, Bonn MJ (1994) Buspirone treatment of anxious alcoholics: a placebo-controlled trial. Arch Gen Psychiatry 51:720-731
20. Kranzler HR, Dellafera SS, McLaughlin L (1995) Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable. Drug Alcohol Depend 40:55-62
21. Kranzler HR, Escobar R, Lee D-K, Meza E (1996) Elevated rates of early discontinuation from pharmacotherapy trials in alcoholics and drug abusers. Alcohol Clin Exp Res 20:16-20
22. Kranzler HR, Tennen H, Penta C, Bohn M (1997) Targeted naltrexone treatment in early problem drinkers, Addict Behav 22: 431-436
23. Marlatt GA, Gordon J (1985) Relapse prevention. Guilford Press, New York
24. Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCL for alcohol dependence. Alcohol Clin Exp Res 18:1162-1167
25. Mello N, Mendelson M, Luksa B, Lukas S (1990) Buprenorphine and naltrexone effects on cocaine self-administration by Rhesus monkeys. J Pharmacol Exp Ther 254:926-39
26. Miller N (1991) Special problems of the alcohol and multiple-drug dependent: clinical interactions and detoxification. In: Frances R, Miller S (eds) Clinical textbook of addictive disorders. Guilford Press, New York, pp 194-218
27. Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR (1997) Effects of naltrexone on cue-elicited craving for alcohol and cocaine. Drug Alcohol Depend 49:9-16
28. Newlin DB, Wong CJ, Pretorius MB, Muntaner C (1991) Alcohol ingestion increases self-report of cocaine-craving: individual differences in craving. Alcohol Clin Exp Res 15:365
29. O'Brien CP, Childress AR, Arndt IO, McLellan AT, Woody GE, Meany I (1988) Pharmacological and behavioral treatments of cocaine dependence: controlled studies. J Clin Psychiatry 49 [Suppl]:17-22
30. O'Malley S, Jaffe A, Chang G, Schottenfeld R, Meyer R, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence; a controlled study. Arch Gen Psychiatry 49:894-98
31. Pfohl D, Allen J, Atkinson R, Knopman D, Malcolm R, Mitchell J, Morley J (1986) Naltrexone hydrochloride (Trexan): a review of serum transaminase elevation at high dosage. National Institute on Drug Abuse Research Monograph #67, NIDA, Rockville, Md., pp 66-74
32. Regier D, Farmer M, Rae D (1990) Comorhidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 264:2511-2518
33. Rosen H, Flemenbaum A, Slater VL (1985) Clinical trial of carbidopa-L-dopa combination for cocaine abuse. Am J Psychiatry 143:1493
34. Ross HE, Glaser FB, Germanson T (1988) The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 45:1023-1031
35. Sobell MB, Maisto SA, Sobell LC, Cooper AM, Cooper TC, Sanders B (1980) Developing a prototype for evaluating alcohol treatment effectiveness. In: Sobell LC, Sobell MB, Ward E (eds) Evaluating alcohol and drug abuse treatment effectiveness: recent advances. Pergamon Press, New York
36. Tiffany ST, Singleton E, Haertzen CA, Henningfield JE (1993) The development of a cocaine craving questionnaire. Drug Alcohol Depend 34:19-28
37. Volpicelli JR, O'Brien C, Alterman A, Hayashida M (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:867-880
38. Volpicelli JR, Clay KL, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP (1997) Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry 54:737-742
39. Waldrop MM (1989) NIDA aims to fight drugs with drugs. Science 245:1443-1444